Published on FierceBiotech (http://www.fiercebiotech.com)

SPOTLIGHT: Tykerb gains priority review

By admin

Created Nov 15 2006 - 7:01pm

Analysts applauded today's announcement that the FDA will provide a priority review for GlaxoSmithKline's cancer therapy Tykerb [1]. Report [2]

analysts
FDA
GlaxoSmithKline
priority
Tykerb

Source URL: http://www.fiercebiotech.com/story/spotlight-tykerb-gains-priority-review/2006-11-16

Links:
[1] http://www.fiercebiotech.com/story/gsk-stakes-claim-to-asco-spotlight/2006-05-24
[2] http://www.newratings.com/analyst_news/article_1423362.html